Who founded BioLamina?

BioLamina was founded by Kristian Tryggvason, Karl Tryggvason in 2009.

Who are BioLamina's investors?

BioLamina's investors include Lauxera Capital Partners, European Investment Bank.

Where is BioLamina headquartered?

BioLamina is headquartered in Stockholm, SE.

BioLamina

Stockholm, SE · Founded 2009 · 117 employees on LinkedIn · 2 known investors

Find your way into BioLamina

203 people in our graph share verified history with the BioLamina team — schools, employers, funds. One of them is your warm intro.

Christian Krog-Jensenunlockedknows Kristian Tryggvason · together at Orexo AB (overlapped)

×3knows the team · via BioLamina

×3knows the team · via Ludwig Institute for Cancer Research

×5knows the team · via Karolinska Institutet

BioLamina develops full-length human recombinant laminin proteins and related cell culture substrates for research and clinical applications. The company's products support the growth and differentiation of pluripotent stem cells, tissue-specific cells, and organoid development in both 2D and 3D culture environments.

Biotech Deep Tech Digital Health Healthtech Medical Devices New Materials

Founders & leadership

BioLamina was founded in 2009 by Kristian Tryggvason and Karl Tryggvason.

Kristian Tryggvason Founder and Board MemberKristian Tryggvason has worked in cell therapy and life sciences since 2009, including founding BioLamina and Alder Therapeutics, and has held board positions at multiple life sciences companies. His background spans research reagent development, therapeutic translation, and building manufacturing and partnership capabilities for early-stage biotechnology.

Karl Tryggvason

Investors · 2

Lauxera Capital Partnerslisted by Lauxera Capital PartnersParis · $22M – $110M

How we know: Lauxera Capital Partners's portfolio page · funding news · Not right? Tell us

European Investment BankreportedLuxembourg

How we know: funding news · biostock.se · Not right? Tell us

Frequently asked questions

What does BioLamina do?: BioLamina develops full-length human recombinant laminin proteins and related cell culture substrates for research and clinical applications. The company's products support the growth and differentiation of pluripotent stem cells, tissue-specific cells, and organoid development in both 2D and 3D culture environments.
Who founded BioLamina?: BioLamina was founded by Kristian Tryggvason, Karl Tryggvason in 2009.
Who are BioLamina's investors?: BioLamina's investors include Lauxera Capital Partners, European Investment Bank.
Where is BioLamina headquartered?: BioLamina is headquartered in Stockholm, SE.